Palantir's Beat Landed on a Record That Had Already Moved On

The number nobody will argue with

Palantir’s own Q2 2026 filed results put revenue at $1.935 billion, up 93% year over year, above the $1.8 billion Wall Street estimate CNBC reported. US commercial revenue reached $764 million, up 149% year over year, while US government revenue reached $809 million, up 90%. Both accelerated from Q1, when Palantir reported US commercial revenue up 133% to $595 million and US government revenue up 84% to $687 million — commercial growth gained 16 points, government gained 6. The dollar gap between the two US lines narrowed from $92 million in Q1 to $45 million in Q2: government still leads Palantir’s US book, but commercial is closing on it. Palantir also raised full-year guidance to 82% revenue growth and 134% US commercial growth, per the filing. On the numbers alone, this is the cleanest beat Palantir has posted since it shipped its AI platform in 2023.

That’s the story every outlet will run tonight. The more useful question, for a site built on the coverage record rather than the headline, is what record this print landed on — because TEXXR’s knowledge graph shows it wasn’t the one you’d expect.

A record that had already moved on

Palantir’s dossier established that coverage of the company turned sharply more financial after 2023: the financial-predicate share of its recorded edges rose from 42% in 2024’s first quarter to 73% of 219 edges in 2026’s first quarter, per TEXXR’s edge-arc tool. That 219-edge count is itself mostly one loud stretch — earnings-day coverage restated across sources and predicates — not a year of steady financial framing.

The fifteen weeks after that print tell a different story. Between April 9 and July 25, the last recorded Palantir edge before the Q2 print, TEXXR’s graph holds 39 edges on the company. Financial predicates account for 7 of them — 18%, down from 73% the quarter before. Partnership (10 edges) and controversy (11 edges) each outnumber financial on their own.

Some of that count is one story wearing several edges: a single Nvidia deal to deploy its Nemotron models for US agencies, announced July 1, generated 4 of the 10 partnership edges. A single TechCrunch piece on Alex Karp’s book manifesto produced 3 of the 11 controversy edges. Collapse each story to one count regardless of how many edges it produced and the picture holds anyway — financial coverage was still the smallest of the three predicates, behind a UK government contract review, a Financial Times report on client and talent risk tied to the company’s alignment with the Trump administration, and a new relationship with Kirkland & Ellis to build AI tools for private-equity fundraising.

The NHS relationship that has run through Palantir’s UK coverage since 2022 kept doing the same work it always has: on June 9, Reuters reported a full government review of the contract, and the Financial Times followed with a piece on Palantir’s fight to keep it. None of that is new — it’s the same three-vocabulary pattern the dossier already traced through this account. What’s new is the timing: it was still running, at volume, in the weeks directly ahead of a quarter this clean.

The stock was retracing before the print, too

TEXXR’s price archive for PLTR runs through July 31 — three days before the print, not through it — and the arc into that final session tells a matching story. PLTR closed at $160.65 on June 1, in the immediate wake of the Q1 beat and the AI-platform narrative it fed. By June 25 it had fallen to $107.27, a decline that erased more than a third of the June 1 level. It then recovered to close the archive’s final session, July 31, at $123.06 — up 14.7% off the June 25 low, but still down 23.4% from the June 1 peak. Both figures come from TEXXR’s own price record; neither the regular close nor the after-hours reaction on the day of this print is in it.

By Monday evening, PLTR was reported to have closed the regular session at $125.65 and printed as high as $143.10 after hours, a reported 13.89% gain. Those two numbers are outside TEXXR’s archive and outside this analysis of it — an after-hours print is a few hours of thin trading, not a settled close, and it isn’t compared against the June-to-July arc above because it wasn’t measured the same way.

What the print does and doesn’t resolve

The dossier calls Palantir tech’s most argued-over stock — three unrelated vocabularies covering the same four letters, with financial framing just one of them and not, on this record, the dominant one heading into earnings. This print is a genuine test of that framing: a quarter where accelerating commercial revenue and a raised guidance figure gave the financial vocabulary something concrete to say, after three months in which the graph mostly wasn’t listening to it.

One earnings beat doesn’t settle which vocabulary wins going forward — the same graph showed financial share both rise sharply (2024→2026) and give most of it back (Q1→the run-up to Q2) inside a single year. What the record does show, cleanly: heading into Monday’s number, Palantir’s coverage was not primarily a financial story, and its stock was still 23% below where it stood two months earlier. The beat has to work against both of those baselines before anyone can call the argument settled.

Sources

The record:

• Q2 2026 revenue of $1.935B, up 93% YoY; US commercial revenue $764M, up 149%; US government revenue $809M, up 90%; raises FY2026 revenue guidance to 82% YoY growth — Palantir Technologies, Form 8-K Exhibit 99.1, 2026-08-03 — original
• Palantir reports Q2 revenue up 93% YoY to $1.94B, vs. $1.8B est., US commercial revenue up 149%, and raises FY 2026 revenue guidance; PLTR jumps 9%+ after hours — CNBC, 2026-08-03 — original · TEXXR record
• Palantir reports Q1 revenue up 85% YoY to $1.63B, with US commercial revenue up 133% and US government revenue up 84% — Reuters, 2026-05-05 — original · TEXXR record
• The UK is conducting a full review of its NHS contract with Palantir amid pressure to use a break clause — Reuters, 2026-06-09 — original · TEXXR record
• Kirkland & Ellis agrees a multiyear deal with Palantir to build an AI tool for PE fundraising advice — Financial Times, 2026-06-04 — original · TEXXR record
• Palantir insiders and investors fear the company's enthusiastic embrace of President Trump — Financial Times, 2026-07-08 — original · TEXXR record
• Inside Palantir's fight to save its £330M, seven-year contract with NHS England — Financial Times, 2026-06-21 — original · TEXXR record

Edges (TEXXR knowledge graph): edge-arc analysis, Palantir hyperedge predicate distribution, 2024Q1–2026Q1 and a manual count over 2026-04-09–2026-07-25 (aggregate; texxr.com/entity/Palantir); hyperedges #390094–390096 (Q1 2026 revenue detail), #405996 (Nvidia Nemotron partnership, one deal reported as four edges).

Prices: data/prices/pltr.json (Massive/Polygon grouped daily, as-traded, through 2026-07-31). The 2026-08-03 regular close and after-hours print are reported market data outside this archive and are not reconciled against it.